Pediatrix Medical Group, Inc. announced that its board of directors has elected James D. Swift, M.D., the Company's chief executive officer, as a director effective March 8, 2023. This appointment fills a seat previously held by Roger J. Medel, M.D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.46 USD | -1.71% | -3.62% | -19.78% |
07/05 | Transcript : Pediatrix Medical Group, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
07/05 | Earnings Flash (MD) PEDIATRIX MEDICAL GROUP Posts Q1 Revenue $495.1M, vs. Street Est of $500.4M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.78% | 62Cr | |
+17.74% | 8.35TCr | |
-29.66% | 6.97TCr | |
-1.06% | 2.65TCr | |
+3.06% | 1.77TCr | |
-12.16% | 1.68TCr | |
+2.47% | 1.57TCr | |
+74.82% | 1.34TCr | |
+73.52% | 1.28TCr | |
+0.76% | 1.27TCr |
- Stock Market
- Equities
- MD Stock
- News Pediatrix Medical Group, Inc.
- Pediatrix Medical Group, Inc. Announces Board Changes